Image (E13564e6 Fbeb 4353 95e2 42f89814e0d1 01)
Amitriptyline Hydrochloride Tablet
Product Images NDC 64330-635
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Amitriptyline Hydrochloride (NDC 64330-635). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Centaur Pharmaceuticals Private Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image (E13564e6 Fbeb 4353 95e2 42f89814e0d1 02)
This is a description of a medication named "Amitriptyline HCI Tablets, USP" manufactured by Centaur Pharmaceuticals Pvt. Ltd. in India. The tablets have a strength of 10 mg per tablet and come in a package of Ceriaud 100 Tablets. The usual dosage is mentioned in the package insert and the tablets are required to be stored at a temperature of 20° to 25°C (68° to 77°F) in a light-resistant container. The package is child-resistant and NDC number mentioned on the package is 64330-630-01. The description also includes the name and address of the manufacturer and the address of the company for whom the medication is manufactured.*
Image (E13564e6 Fbeb 4353 95e2 42f89814e0d1 03)
This is a drug label for Amitriptyline HCI 25mg tablets manufactured by Centaur Pharmaceuticals Pvt. Ltd. in India. The tablets are meant to be stored at controlled room temperature and dispensed in a tight, light-resistant container. The package is child-resistant and comes with a medication guide. The drug is available in a 100 tablet package with NDC 64330-631-01. The recommended use of the drug is not mentioned, and one is advised to check the package insert for instructions.*
Image (E13564e6 Fbeb 4353 95e2 42f89814e0d1 04)
This is a medication packaging for Amitriptyline HCI tablets, containing 50 mg each, manufactured by Centaur Pharmaceuticals Pvt. Ltd. The usual dosage is not available. The packaging is child-resistant and should be kept out of reach of children. A medication guide is provided separately.*
Image (E13564e6 Fbeb 4353 95e2 42f89814e0d1 05)
This is a description of Amitriptyline HCI Tablets, USP manufactured by Centaur Pharmaceuticals Pvt. Ltd. in India. Each tablet contains 75mg of Amitriptyline HCI, and the usual dosage information is available in the package insert. This medication should be stored at room temperature and dispensed in a light-resistant container. The package is child-resistant, and it should be kept away from children. The NDC number for this medication is 64330-633-01.*
Image (E13564e6 Fbeb 4353 95e2 42f89814e0d1 06)
This text provides information about the manufacturing and distribution of Amitriptyline HCI tablets by Centaur Pharmaceuticals Pvt. Ltd. The tablets come in a package of 100 and each tablet contains 100mg of the medication. The usual dosage is not specified and the medication guide is provided separately. The tablets should be stored at controlled room temperature and kept in a tight, light-resistant container. The package is child-resistant and should be kept out of reach of children.*
Image (E13564e6 Fbeb 4353 95e2 42f89814e0d1 07)
This is a description for Amitriptyline HCI Tablets, manufactured by Centaur Pharmaceuticals Pvt. Ltd. in Pune, India, and distributed in Mumbai, India. The tablets are for prescription use only and come in a child-resistant package. Each tablet contains 150 mg of Amitriptyline HCI, USP, and the usual dosage is outlined in the package insert. They need to be stored between 20° and 25°C (68° to 77°F) in a light-resistant container. Additionally, it recommends dispensing them with a Medication Guide provided separately. NDC number 64330-635-01 is assigned to the product.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
